GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (NSE:ORTINGLOBE) » Definitions » YoY Rev. per Sh. Growth

Ortin Global (NSE:ORTINGLOBE) YoY Rev. per Sh. Growth : -79.06% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ortin Global YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Ortin Global's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was -79.06%.

Ortin Global's Revenue per Share for the three months ended in Sep. 2024 was ₹0.07.


Ortin Global YoY Rev. per Sh. Growth Historical Data

The historical data trend for Ortin Global's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Global YoY Rev. per Sh. Growth Chart

Ortin Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.84 -95.84 0.94 -23.70 -66.35

Ortin Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -67.11 -88.25 -90.65 -86.27 -79.06

Ortin Global YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Ortin Global's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2024 )
=(Revenue per Share (A: Mar. 2024 )-Revenue per Share (A: Mar. 2023 ))/ | Revenue per Share (A: Mar. 2023 ) |
=(2.597-7.718)/ | 7.718 |
=-66.35 %

Ortin Global's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(0.067-0.32)/ | 0.32 |
=-79.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortin Global YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Ortin Global's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Global Business Description

Traded in Other Exchanges
Address
Road No.12, Mayfair Gardens, 8-2-682/3/A & 3B, Flat No. 201, 2nd Floor, Banjara Hills, Khairatabad, Hyderabad, TG, IND, 500034
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. The company has two operating segments, including Manufacture and Trading. The company generates the majority of its revenue from the Trading division, which involves trading of Pharmaceuticals and medical Formulations.

Ortin Global Headlines

No Headlines